Table 2.
Categorization of individuals based on prior exposure.
| Group | N | Unexposed N | Naturally Exposed N | Vaccinated N |
|---|---|---|---|---|
| Dutch village cohort | 951 | 21 | 74 | N/A |
| Dutch blood bank cohort | 981 | 77 | 21 | N/A |
| Australian pre-vaccination cohort | 961 | 68 | 28 | N/A |
| Australian post-vaccination cohort | 582 | N/A | N/A | 58 |
1Categorization based on IGRA outcome and phase II IgG IFA titer. Those who were scored negative by IGRA and had a negative phase II IgG IFA titer in 2020/21 (and 2014 and 2015 in the Dutch Village cohort) were categorized as Unexposed. Naturally Exposed was defined by a positive or borderline IGRA and/or a positive phase II IgG IFA titer in 2020/21 (and 2014 and 2015 in the Dutch Village cohort)
2Categorization based on Q-VAX vaccination during this study. Post-vaccination samples were treated as an independent sample set from those samples assessed pre-vaccination.
N/A, not applicable.